CLEVELAND, Oct. 1 /PRNewswire/ -- Many of the nation's top leaders in health care will converge Oct. 5-7 at Cleveland Clinic's 7th Annual Medical Innovation Summit.
The Clinic's Medical Innovation Summit is unprecedented in health care. It draws 900 decision-makers from throughout the industry for a three-day dialogue on the future of innovation. At a time of fundamental change in the health care system, this gathering will examine the newest cancer-fighting technologies as well as what the future prospects are for innovation in a post-reform era.
"Cleveland Clinic is an important innovator in the global health care system," said Fred Hassan, Chairman and CEO, Schering-Plough Corp. "This Summit is of special importance at a time when all stakeholders are urgently engaged in efforts to improve quality, success, choice and innovation in health care."
- Sam Palmisano, CEO, IBM
- Margaret Hamburg MD, FDA Commissioner
- Dan Vasella, MD, CEO, Novartis
- David Brennan, CEO, AstraZeneca
- Richard Clark, CEO, Merck
- Greg Lucier, CEO, Life Technologies
- Fred Hassan, CEO, Schering-Plough
- Sol Barer Ph.D., CEO, Celgene
- Kari Stefansson M.D., CEO, deCODE genetics
- Sir Bruce Ponder, M.D., Ph.D., Director, Cambridge Research Institute
For a complete list of speakers, visit http://www.clevelandclinic.org/innovations/summit
"The Summit delivers chief executives who provide their personal perspective on the key contemporary technology issues," said Christopher Coburn, Executive Director, Cleveland Clinic Innovations, and conference organizer. "Those issues include the clinical benefit of genotyping, how new IT technologies will remake the delivery of care, specific ways health care reform will change medical innovation and much, much more. We are proud to stage this event, which will provide important insights for anyone interested in new technology and its application to help patients."
About Cleveland Clinic Innovations
Innovations, the corporate venturing arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin-off companies, licensees and equity partnerships.
Follow on Twitter: @CleveClinicNews,#CCInnovation
SOURCE Cleveland Clinic